Thomas Feldthus

Biography

 Thomas Feldthus, M.Sc., MBA, Co-founded Saniona AB in 2011, has been its Executive Vice President and Chief Financial Officer since 2015 and 2014 respectively. Mr. Feldthus co-founded Symphogen A/S in 2000 and served as its Chief Financial Officer. Mr. Feldthus served as the Chief Financial Officer of WntResearch AB until June 01, 2015. He served as a Vice President of Business Development at Symphogen A/S. Mr. Feldthus served as an Investment Manager of Novo A/S since January 2000. From 1996 to 1999, he served as a Corporate Development Manager and Investment Manager of Novo Nordisk A/S and prior to that, Director of Business Development at Cheminova Agro A/S. He served as a Director of Saniona AB. He has an extensive experience with business development, international sales, marketing and project management. Mr. Feldthus is Co-Founder and Director of Leukotech A/S. He holds a M.Sc. from the Technical University of Denmark and an MBA (Sloan Fellow) from London Business School.

Research Interest

Neurology